Capital World Investors’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-235,164
Closed -$18.8M 515
2016
Q3
$18.8M Buy
235,164
+1,168
+0.5% +$94.3K ﹤0.01% 406
2016
Q2
$18.3M Sell
233,996
-149,740
-39% -$10.7M ﹤0.01% 405
2016
Q1
$21.1M Buy
383,736
+73
+0% +$3.98K 0.01% 396
2015
Q4
$23.7M Buy
383,663
+537
+0.1% +$33.9K 0.01% 409
2015
Q3
$24.2M Buy
383,126
+233,126
+155% +$16.6M 0.01% 407
2015
Q2
$11M Hold
150,000
﹤0.01% 487
2015
Q1
$9.81M Hold
150,000
﹤0.01% 491
2014
Q4
$9.76M Buy
+150,000
New +$9.66M ﹤0.01% 491

Other funds holding STJ

Capital World Investors's STJ Position: Q4 2016 in Review

Capital World Investors sold out of St Jude Medical (STJ) in Q4 2016, closing a stake of 235,164 shares — an estimated $18.8M sold.

Capital World Investors first reported a position in STJ in Q4 2014 and held it in 8 quarters. The position peaked at $24.2M in Q3 2015. 551 funds tracked by Wall St. Rank hold STJ as of Q4 2016.

  • Capital World Investors reported no remaining St Jude Medical position as of Q4 2016 after selling out during the quarter.
  • Capital World Investors sold 235,164 St Jude Medical shares in Q4 2016, an estimated $18.8M.
  • Capital World Investors first reported a position in St Jude Medical in Q4 2014 and held it in 8 quarters.
  • Capital World Investors's St Jude Medical position peaked at $24.2M in Q3 2015.
  • 551 funds tracked by Wall St. Rank held St Jude Medical as of Q4 2016.

Based on Capital World Investors's 13F filing for Q4 2016, filed 15 Feb 2017.